Tag: SINO

Blue Horseshoe Stocks: Options, Updates & More

Twitter, Inc. TWTR – Options Recap

Our formulated ideas for the TWTR options chain from yesterday morning’s premarket report turned out to offer up some fantastic chances to profit. We spotted just the right conditions before market hours and pounced, designating the TWTR Weekly $15-16 Calls to be our targets.

It certainly wasn’t the first time we’ve used Twitter in this manner, and it probably won’t be the last. Regardless of which set of contracts was chosen, multi-bag, single-session gains were there for the taking:

$15 Calls – Range: .30-1.49 – Max Gain: 397%
$15.50 Calls – Range: .40-1.00 – Max Gain: 150%
$16 Calls – Range: .21-.61 – Max Gain: 190%
_________

FRESH Options Idea: UPS 05/05 $108-111 Calls

Akebia Therapeutics, Inc. AKBA

An honorable mention from yesterday’s report was AKBA, which we tagged for observation after noticing some abnormal premarket activity on our routine morning scan.

The stock traded in a respectable range from a low of 11.08 to as high as 13.94. That works out to an intraday move of 26% which came on massive volume of an astonishing 110X the 30-day average! It also managed to close holding roughly half of its daily increase at 12.50, so we’re definitely going to be on the lookout for continued activity in AKBA, which could include a dip-and-rip pattern at some point.

American Leisure Holdings, Inc. AMLH

We tracked AMLH over some monstrous gains from the end of March, to earlier this month. The move took it from super-subpenny lows of .0003 to a high of .007 (+2233%), so we weren’t at all surprised to see a consolidation period follow over the next several sessions.

The stock did however find support and make a reversal off of the .0029 level beginning last week, and heading back up to its previous high of .007 yesterday, marking a 141% swing. We’ll look for the stock to break through that resistance at .007, which would effectively put AMLH into Blue Sky Breakout mode, and trading at its highest prices since the Fall of 2015.

Extended Watchlist:
ALIM, BLDV, MDGS, SSKN, SINO, PURA(News)

Blue Horseshoe Stocks: GIGL Explodes & More

Giggles N’ Hugs, Inc. GIGL

We were exceptionally pleased with the performance of GIGL after including it in Friday’s premarket report, and our timing really couldn’t have been any better. The stock had been trading sideways for months, without so much as a spike, yet it still broke out for a monstrous single-session move.

GIGL traded up from an early low of .0053, smashed through the penny barrier, and hurtled its way to an impressive high of .024. That worked out to an intraday push of 353% and it came on record volume.

For those reasons, we’ll certainly be ready to continue monitoring the activity in this play. We’ll of course allow for the possibility of some course correction, but the odds of seeing either a continued increase, or a dip-and-rip scenario, seem reasonably high at this point.

LIG Assets, Inc. LIGA

We also got a pretty good performance out of LIGA, which was another inclusion from Friday’s report. The move didn’t quite rise to the magnitude of the aforementioned stock, it did attain double-bagger status with a significant gain opportunity.

From a low of .001, we watched as LIGA shot to a high of .0022 inside of the first two hours of trading. That was good for quick gains of up to 120%    Perhaps just as importantly, the stock maintained more than half of its daily advance, so we’ll be keeping an eye peeled in sessions to come.

Merrimack Pharmaceuticals, Inc. MACK

We also want to draw attention to MACK this morning, a stock that we haven’t visited in quite some time. Following the establishment of a new 52-week (and indeed, a three year) low on Friday, a bombshell development hit wires this morning and is really causing a stir.

PPS has increased considerably in premarket trading as the company announced that it has sold a pancreatic cancer drug, among other assets, for a cool billion dollars. (>>View PR)

Whenever a major catalytic event such as this transpires, we always like to monitor the situation on the tail end. Hypothetically, a return to its pricing from around this time last year, from this point, would carry a gain of around 100%

Extended Watchlist:
ACNV, GEVO, DRYS,TLOG, SINO, DCIX,

Blue Horseshoe Stocks: CNAT Recap & More

Conatus Pharmaceuticals, Inc. CNAT

We were fairly confident that at least one of the pharma news plays we put forth in yesterday’s premarket report would turn out a promising session, and CNAT definitely rose to the occasion.

We highlighted it, of course, because of a big collaboration and licensing deal for one of the company’s drugs, which adds a quick $50M cash to the books almost immediately, and even more down the road.

After gapping up considerably in the premarket, the stock underwent a dip-and-rip scenario which carried it to a daily low of 4.27 before it pushed its way up to a high of 5.50. That marked a solid intraday upswing of 29% and came on four times the three-month average volume.

ACADIA Pharmaceuticals, Inc. ACAD

ACAD was the other play off of our pharma watchlist that provided us with significant opportunities, which were even bigger than the previously mentioned stock.

We offered an options idea, the ACAD Weekly $28-31 Calls, and all but a couple sets of contracts in that range produced respectable intraday moves.

$28 Calls – Range: .70-1.66 – Max Gain: 137%
$28.50 Calls – Range: .59-1.40 – Max Gain: 137%
$29 Calls – Range: .40-.80 – Max Gain: 100%
$29.50 Calls – Range: .30-.70 – Max Gain: 133%
$30 Calls – Range: .18-.50 – Max Gain: 178%

______

NIKE, Inc. NKE – Fresh Options Idea

NKE is coming off a post-market earnings beat yesterday, so we want to enter an idea into the logs for this situation.

We’re going to be monitoring the activity in the NKE Weekly $52.50-54 Calls for possible daytrades and/or swing trades into the end of the week.

Extended Watchlist:
LEOM, MMEG, INO, ESEA, SINO, DCIX, DRYS, HIMX(Bottom-Watch)